Marshall Wace’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.8M | Buy |
725,068
+581,575
| +405% | +$11.3M | 0.02% | 786 |
|
|
2025
Q4 | $3.09M | Buy |
143,493
+38,380
| +37% | +$809K | ﹤0.01% | 1376 |
|
|
2025
Q3 | $2.03M | Buy |
+105,113
| New | +$1.87M | ﹤0.01% | 1615 |
|
|
2025
Q2 | – | Sell |
-27,197
| Closed | -$1.74M | – | 3156 |
|
|
2025
Q1 | $1.74M | Buy |
+27,197
| New | +$2.86M | ﹤0.01% | 1529 |
|
|
2024
Q4 | – | Sell |
-42,938
| Closed | -$5.36M | – | 3015 |
|
|
2024
Q3 | $5.36M | Sell |
42,938
-397
| -0.9% | -$54.9K | 0.01% | 970 |
|
|
2024
Q2 | $6.85M | Buy |
43,335
+39,992
| +1,196% | +$5.14M | 0.01% | 878 |
|
|
2024
Q1 | $433K | Buy |
+3,343
| New | +$410K | ﹤0.01% | 1988 |
|
|
2023
Q4 | – | Sell |
-245,928
| Closed | -$29.8M | – | 2636 |
|
|
2023
Q3 | $29.8M | Buy |
245,928
+186,886
| +317% | +$21.1M | 0.06% | 324 |
|
|
2023
Q2 | $6.76M | Sell |
59,042
-120,217
| -67% | -$15.5M | 0.01% | 900 |
|
|
2023
Q1 | $24.7M | Sell |
179,259
-6,746
| -4% | -$875K | 0.06% | 390 |
|
|
2022
Q4 | $24.1M | Buy |
+186,005
| New | +$21.6M | 0.06% | 397 |
|
|
2022
Q1 | – | Sell |
-503,638
| Closed | -$45.4M | – | 4054 |
|
|
2021
Q4 | $45.4M | Buy |
503,638
+500,289
| +14,938% | +$42.8M | 0.09% | 240 |
|
|
2021
Q3 | $310K | Sell |
3,349
-16,170
| -83% | -$1.25M | ﹤0.01% | 2633 |
|
|
2021
Q2 | $1.52M | Sell |
19,519
-3,617
| -16% | -$274K | 0.01% | 1600 |
|
|
2021
Q1 | $1.73M | Buy |
+23,136
| New | +$2.13M | 0.01% | 1395 |
|
|
2019
Q4 | – | Sell |
-24,153
| Closed | -$1.82M | – | 2036 |
|
|
2019
Q3 | $1.82M | Buy |
+24,153
| New | +$2.85M | 0.02% | 798 |
|
|
2019
Q2 | – | Sell |
-5,967
| Closed | -$711K | – | 1817 |
|
|
2019
Q1 | $711K | Sell |
5,967
-4,439
| -43% | -$571K | 0.01% | 1035 |
|
|
2018
Q4 | $1.14M | Buy |
+10,406
| New | +$1.3M | 0.01% | 878 |
|
|
2018
Q3 | – | Sell |
-3,667
| Closed | -$485K | – | 1273 |
|
|
2018
Q2 | $485K | Sell |
3,667
-4,321
| -54% | -$407K | 0.01% | 581 |
|
|
2018
Q1 | $592K | Buy |
7,988
+1,845
| +30% | +$123K | 0.02% | 331 |
|
|
2017
Q4 | $342K | Sell |
6,143
-21,670
| -78% | -$1.15M | 0.01% | 337 |
|
|
2017
Q3 | $1.25M | Buy |
+27,813
| New | +$1.11M | 0.06% | 201 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1108 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1125 |
|
|
2015
Q2 | – | Sell |
-11,296
| Closed | -$150K | – | 1036 |
|
|
2015
Q1 | $150K | Buy |
+11,296
| New | +$151K | ﹤0.01% | 760 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM